10. EMPLOYEE EQUITY INCENTIVE PLANS

3 Months Ended

Mar. 31, 2017

Equity Incentive Plans - Options

10. EMPLOYEE EQUITY INCENTIVE PLANS

NOTE 10 – EMPLOYEE EQUITY INCENTIVE PLANS

The Company’s shareholders approved our 2014 Plan in June 2014, our 2015 Plan in December 2015, our 2016 Equity Incentive Plan (“2016 Plan”) in October 2016 and our 2017 Equity Incentive Plan in December 2016 (“2017 Plan”, together with the 2014 Plan, 2015 Plan and 2016 Plan, the “Plans”). The Plans are identical, except for number of shares reserved for issuance under each. As of March 31, 2017, the Company had granted an aggregate of 29,006,347 securities under the plans, with 11,094,084 available for future issuances.

The Plans provide for the grant of incentive stock options to our employees and our parent and subsidiary corporations’ employees, and for the grant of non-statutory stock options, stock bonus awards, restricted stock awards, performance stock awards and other forms of stock compensation to our employees, including officers, consultants and directors. Our Plans also provide that the grant of performance stock awards may be paid out in cash as determined by the Committee.

During the three months ended March 31, 2017, the Company granted options to purchase 2,069,000 shares of common stock for ten years. The fair value of $1,724,020, was determined using the Black-Scholes Option Pricing Model, assuming approximately 1.88% to 2.35% risk-free interest, 0% dividend yield, 104.96% to 110.16% volatility, and expected life of five to ten years and will be charged to operations over the vesting terms of the options.

The summary terms of the issuances are as follows:

Exercise		Number of		Vesting
Price		Options		Terms
$	0.81		5,000	Immediately
	0.82		150,000	Quarterly over two years
	0.85		150,000	Quarterly over one year
	0.87		125,000	Immediately
	0.89		425,000	Monthly over one year
	0.89		90,000	Quarterly over two years
	0.95		400,000	Quarterly over two years
	0.98		24,000	Monthly over two years
	1.05		50,000	Immediately
	1.05		95,000	Monthly over two years
	1.05		60,000	Monthly over one year
	1.06		60,000	Monthly over one year
	1.07		110,000	Monthly over one year
	1.07		325,000	Monthly over two years
	0.95		2,069,000

Stock options outstanding and exercisable on March 31, 2017 are as follows:

Exercise		Number of		Remaining Life		Number of
Price		Options		In Years		Options Exercisable
$	0.10		1,500,000		7.18		1,250,000
	0.50		549,006		7.83		549,006
	0.51		2,041,779		9.52		1,600,101
	0.60		105,000		8.03		105,000
	0.77		1,600,000		9.70		283,332
	0.80		145,000		8.80		145,000
	0.81		5,000		9.96		—
	0.82		150,000		9.96		—
	0.83		100,000		8.80		—
	0.85		150,000		9.92		—
	0.86		5,400,000		9.73		1,749,997
	0.87		125,000		9.98		125,000
	0.89		615,000		9.79		116,672
	0.90		1,860,413		8.70		1,860,413
	0.95		400,000		9.88		30,000
	0.98		24,000		9.82		10,000
	1.00		837,494		8.72		241,660
	1.05		586,250		9.25		459,276
	1.06		60,000		9.85		3,000
	1.07		435,000		9.78		81,662
			16,688,942		9.14		8,610,119

A summary of the stock option activity for the three months ended March 31, 2017:

						Weighted-Average
				Weighted-Average		Remaining		Aggregate
	Shares			Exercise Price		Contractual Term		Intrinsic Value
Outstanding at December 31, 2016		14,824,158			0.52		9.37	$	4,566,717
Grants		2,069,000			0.95		9.60		—
Exercised		(79,214	)		0.50		8.80
Forfeiture/Canceled		(125,002	)	$	0.51		8.80		—
Outstanding at March 31, 2017		16,688,942		$	0.75		9.14	$	3,513,787
Exercisable at March 31, 2017		8,610,119		$	0.68		8.89	$	2,429,690

The aggregate intrinsic value of outstanding stock options was based on options with an exercise price less than the Company’s common stock price of $0.955 as of March 31, 2017, which would have been received by the option holders had those option holders exercised their options as of that date.

Option valuation models require the input of highly subjective assumptions. The fair value of stock-based payment awards was estimated using the Black-Scholes option model with a volatility figure derived from an index of historical stock prices of comparable entities until sufficient data exists to estimate the volatility using the Company’s own historical stock prices. Management determined this assumption to be a more accurate indicator of value. The Company accounts for the expected life of options based on the contractual life of options for non-employees.

The fair value of all options vesting during the three months ended March 31, 2017 and 2016 of $2,276,443 and $670,767, respectively.  Unrecognized compensation expense of $4,973,087 at March 31, 2017 will be expensed in future periods.